Healthy Lifestyle

     Radiation therapy is a cancer treatment that uses high-energy beams to kill cancer cells. It is often used to treat breast cancer, either after surgery to remove the tumor (adjuvant therapy) or to shrink the tumor before surgery (neoadjuvant therapy). The benefits of radiation therapy for breast cancer patients include: It can help to kill cancer cells that may remain after surgery. It can help to reduce the risk of the cancer coming back (recurrence). It can be used to treat cancer that has spread to other parts of the body (metastatic cancer). The risks of radiation therapy for breast cancer patients include: Skin irritation, redness, and peeling. Fatigue. Dry mouth. Hair loss in the treated area. Lymphedema, a swelling of the arm or hand on the side of the breast that was treated. In very rare cases, radiation therapy can cause cancer in other parts of the body.      The decision of whether or not to have radiation therapy for breast cancer is a personal one that sho

     I can help you with that. Here are some of the early signs and symptoms of oral cancer that you should be aware of: A lump or sore in the mouth that does not heal Pain in the mouth or throat Red or white patches in the mouth Thickening of the lining of the mouth Bleeding gums Numbness in the mouth or lips Difficulty chewing or swallowing Ear pain If you notice any of these symptoms, it is important to see your doctor or dentist right away. Early diagnosis and treatment are important for a good outcome. Here are some things you can do to help prevent oral cancer: Don't smoke or use smokeless tobacco. Limit your alcohol intake. Practice good oral hygiene. Get regular dental checkups and cleanings. Get vaccinated against human papillomavirus (HPV). HPV is a virus that can cause oral cancer. The HPV vaccine is available for people ages 9 to 45. By following these tips, you can help reduce your risk of developing oral cancer. Here are some additional things you can d

     Atezolizumab (Tecentriq) is a cancer immunotherapy drug that works by blocking a protein called programmed death-ligand 1 (PD-L1). PD-L1 is a protein that helps cancer cells evade the immune system. By blocking PD-L1, atezolizumab helps the immune system recognize and attack cancer cells.      Atezolizumab is approved by the U.S. Food and Drug Administration (FDA) to treat a variety of cancers, including: Non-small cell lung cancer (NSCLC) Metastatic triple-negative breast cancer Advanced bladder cancer Head and neck cancer Merkel cell carcinoma Hodgkin lymphoma MSI-high solid tumors      Atezolizumab is given as an infusion (drip) into a vein. The recommended dose and schedule vary depending on the type of cancer being treated. Atezolizumab is generally well-tolerated, but it can cause some side effects, such as: Fatigue Infusion reactions Rash Diarrhea Nausea and vomiting Pneumonitis (inflammation of the lungs) Hepatotoxicity (liver damage) Hypothyroidism (low th